Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin plus acid suppression for chemoprevention in Barrett's esophagus (pilot study)
2011-000264-10Phase 3Completed
- Sponsor
- Instituto Aragonés de Ciencias de la Salud
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of melatonin in Barrett's esophagus, sponsored by Instituto Aragonés de Ciencias de la Salud. Primary endpoint: Oxidative stress markers. Started Nov 2011; status: completed.
02
Drugs
melatonin
03
Conditions
Barrett's esophagus
Beyond the preview
Go deeper on 2011-000264-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000264-10.